ArticleMolecules (Basel, Switzerland)2016

Lead Discovery of Type II BRAF V600E Inhibitors Targeting the Structurally Validated DFG-Out Conformation Based upon Selected Fragments.

Qingwen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.